Search results
Will Weakness in BioNTech SE's (NASDAQ:BNTX) Stock Prove Temporary Given Strong Fundamentals?
Simply Wall St. via Yahoo Finance· 2 months agoWith its stock down 7.5% over the past three months, it is easy to disregard BioNTech (NASDAQ:BNTX)....
Is Weakness In BioNTech SE (NASDAQ:BNTX) Stock A Sign That The Market Could be Wrong Given Its...
Simply Wall St. via Yahoo Finance· 1 year agoWith its stock down 11% over the past three months, it is easy to disregard BioNTech (NASDAQ:BNTX)....
Time To Worry? Analysts Are Downgrading Their BioNTech SE (NASDAQ:BNTX) Outlook
Simply Wall St. via Yahoo Finance· 7 months agoMarket forces rained on the parade of BioNTech SE (NASDAQ:BNTX) shareholders today, when the...
Is BioNTech SE's (NASDAQ:BNTX) Latest Stock Performance A Reflection Of Its Financial Health?
Simply Wall St. via Yahoo Finance· 2 years agoMost readers would already be aware that BioNTech's (NASDAQ:BNTX) stock increased significantly by...
BioNTech SE's (NASDAQ:BNTX) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market...
Simply Wall St. via Yahoo Finance· 8 months agoWith its stock down 12% over the past month, it is easy to disregard BioNTech (NASDAQ:BNTX)....
BioNTech SE (NASDAQ:BNTX) Shares Could Be 35% Above Their Intrinsic Value Estimate
Simply Wall St. via Yahoo Finance· 7 months agoKey Insights The projected fair value for BioNTech is US$76.97 based on 2 Stage Free Cash Flow to...
A Look At The Fair Value Of BioNTech SE (NASDAQ:BNTX)
Simply Wall St. via Yahoo Finance· 2 years agoHow far off is BioNTech SE (NASDAQ:BNTX) from its intrinsic value? Using the most recent financial...
BioNTech SE's (NASDAQ:BNTX) market cap surged US$4.0b last week, private equity firms who have a lot...
Simply Wall St. via Yahoo Finance· 2 years agoIf you want to know who really controls BioNTech SE (NASDAQ:BNTX), then you'll have to look at the...
Insiders own 20% of BioNTech SE (NASDAQ:BNTX) shares but private equity firms control 44% of the...
Simply Wall St. via Yahoo Finance· 9 months agoKey Insights The considerable ownership by private equity firms in BioNTech indicates that they...
BioNTech Stock Crumbles After 2023 Outlook Misses By Almost $3 Billion
Investor's Business Daily· 1 year agoBioNTech said Monday it expects roughly $5.4 billion in sales of its Covid vaccine this year, widely...